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a b s t r a c t 
Carnitine palmitoyl transferase 2 (CPT-2) is a key enzyme in the mitochondrial fatty acid metabolism. The 
active site is comprised of a Y-shaped tunnel with distinct binding sites for the substrate acylcarnitine 
and the cofactor CoA. We investigated the thermodynamics of binding of four inhibitors directed against 
either the CoA or the acylcarnitine binding sites using isothermal titration calorimetry (ITC). CPT-2 is a 
monotopic membrane protein and was solubilized by β-octylglucoside ( β-OG) above its critical micellar 
concentration (CMC) to perform inhibitor titrations in solutions containing detergent micelles. The CMC 
of β-OG in the presence of inhibitors was measured with ITC and small variations were observed. The 
inhibitors bound to rat CPT-2 (rCPT-2) with 1:1 stoichiometry and the dissociation constants were 
in the range of K D = 2–20 μM. New X-ray structures and docking models of rCPT-2 in complex with
inhibitors enable an analysis of the thermodynamic data in the context of the interaction observed for 
the individual binding sites of the ligands. For all ligands the binding enthalpy was exothermic, and 
enthalpy as well as entropy contributed to the binding reaction, with the exception of ST1326 for which 
binding was solely enthalpy-driven. The substrate analog ST1326 binds to the acylcarnitine binding site 
and a heat capacity change close to zero suggests a balance of electrostatic and hydrophobic interactions. 
An excellent correlation of the thermodynamic (ITC) and structural (X-ray crystallography, models) data 
was observed suggesting that ITC measurements provide valuable information for optimizing inhibitor 
binding in drug discovery. 
C © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical 
Societies. Open access under CC BY-NC-ND license.. Introduction 
The carnitine palmitoyltransferase system (CPT) plays an essential 
ole in the β-oxidation of long-chain fatty acids. This transport system 
onsists of three separate proteins. Carnitine palmitoyltransferase 1 
CPT-1), located on the mitochondrial outer membrane, catalyzes the 
onversion of long-chain fatty acid-CoA esters to acylcarnitine esters 
 1 –3 ]. Carnitine acylcarnitine translocase (CACT), an integral protein 
f the mitochondrial inner membrane, facilitates the transport of the 
cylcarnitine esters from the cytosol into the mitochondrial matrix. 1 Contributed equally to this work. 
* Corresponding author. Address: Division of Biophysical Chemistry, Biozentrum, 
niversity of Basel, Klingelbergstrasse 50 / 70, CH-4056 Basel, Switzerland. Tel.: + 41 
1 267 2190; fax: + 41 61 267 2189. 
E-mail address: joachim.seelig@unibas.ch (J. Seelig). 
211-5463 c © 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of Europe
ttp://dx.doi.org/10.1016/j.fob.2013.04.003 On the luminal side of the mitochondrial inner membrane carnitine 
palmitoyltransferase 2 (CPT-2) converts the carnitine esters back to 
CoA esters [ 4 ]. Once regenerated, the CoA esters can be oxidized in 
the β-oxidation pathway. Impaired activity of the CPT-enzymes due 
to inherited gene mutations is the cause of CPT-deﬁciency, which can 
manifest itself in various degrees of clinical severity [ 2 , 5 ]. Metabolic 
abnormalities of the CPT system may result in different human dis- 
eases such as diabetes, obesity or myocardial ischemia and the CPT 
acyl-carnitine shuttle has hence attracted attention as a target for 
therapeutic intervention [ 4 , 5 ]. 
The discovery of a novel class of sulfonamide CPT inhibitors was 
recently reported [ 6 ]. Here, we characterize for selected compounds 
the binding mode of these inhibitors in comparison to another class 
of piperidine-based CoA-site binders and also to the established CPT 
inhibitor ST1326 by calorimetric and crystallographic studies. We 
focus on interaction with full-length CPT-2 from rat that was ex- 
pressed in Escherichia coli (rCPT-2) because its crystal structure has 
been solved in contrast to CPT-1, for which no experimental structure 
of the catalytic domain is available. Solubilization and puriﬁcation an Biochemical Societies. Open access under CC BY-NC-ND license.
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Table 1 
Molecular weights, structures, IC 50 values and binding sites for inhibitors 1–4. 
MW (Da) Structure IC 50 
a ( μM) 
rCPT-2 (binding 
site) 
Inhibitor 1 423 .5 2 .8 CoA site 
Inhibitor 2 449 .5 0 .15 CoA site 
Inhibitor 3 518 .9 0 .78 CoA site 
Inhibitor 4 
(ST1326) 
399 .6 0 .38 Acylcarnitine 
site 
a IC 50 values were measured by a spectrophotometric assay as described in Section 2 . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 of the monotopic membrane protein rCPT-2 in presence of the de-
tergent β-octyl glucoside ( β-OG) yielded homogeneous and active
enzyme [ 7 , 8 ]. X-ray crytallographic data of rCPT-2 and its complex
with the substrate analog and inhibitor ST1326 showed that the ac-
tive site of the protein is located in a Y shaped tunnel and that this
tripartite tunnel comprises binding sites for acyl, carnitine and CoA
moieties [ 7 –10 ]. As rCPT-2 is not soluble in aqueous buffer without
addition of detergents, one goal of the present work was to investigate
whether isothermal titration calorimetry (ITC) can be used to quan-
titate the interactions between rCPT-2 and inhibitors in presence of
micellar detergent. We previously studied the interaction of a small
hydrophobic peptide, cynnamycin, with a phospholipid in buffer that
contains β-OG above its critical micellar concentration (CMC) and
demonstrated that the binding reaction of the hydrophobic peptide
and phospholipid could indeed be measured with ITC [ 11 , 12 ]. 
In the present study we have ﬁrst investigated the inﬂuence of
four different rCPT-2 inhibitors on the CMC of β-OG. Secondly, the
binding of the inhibitors to rCPT-2 was measured with ITC in the
same micellar environment. The calorimetric titration provided the
reaction enthalpy, H 0 , and the dissociation constant K D , from which
the changes in free energy, G 0 , and entropy, S 0 , were calculated.
For one inhibitor we also measured the change in heat capacity, C 0 p ,
by performing ITC experiments at different temperatures, because
C 0 p provides insight into the hydrophobic / hydrophilic balance of
inhibitor binding. Finally, we used crystal structures and docking
models of rCPT-2 with bound inhibitors for the interpretation of the
thermodynamic parameters. 
2. Materials and methods 
2.1. Protein preparation 
Full-length rCPT-2 (658 aa; MW 73.5 kDa) with an amino-terminal
His 6 -tag was expressed in E. coli as described [ 8 ]. The protein
was stored in 25 mM Tris / HCl pH 8, 150 mM NaCl, 2 mM tris-(2-
carboxylethyl)-phosphine–HCl (TCEP) supplemented with 1% (w / v)
β-OG ( ∼34 mM). Under these conditions rCPT-2 was found to be
monomeric and monodisperse, as determined by analytical ultracen-
trifugation [ 7 ]. Variation of the β-OG concentration to lower or higher
values caused protein aggregation or competitive binding of β-OG to
the acylcanitine site of rCPT-2, respectively. This precluded a titration
of the detergent and extrapolation of the binding data to zero β-OG
concentration. 
2.2. Inhibitors 
The structures of inhibitors 1–4 are given in Table 1 . Details about
the synthesis, structure–activity relationship (SAR) and pharmacol-
ogy of these compounds are reported in [ 6 ]. 2.3. Dependency of β-OG critical micellar concentration (CMC) on 
inhibitor concentration 
For ITC experiments the inhibitors were ﬁrst dissolved in
dimethylsulfoxide (DMSO) at a concentration of 10 mM and aliquots
of the stock solutions were diluted into the measurement buffer to a
ﬁnal concentration of 100 μM in the presence of 1% DMSO (v / v). Demi-
cellization experiments of β-OG with and without co-dissolved in-
hibitor were performed with either Omega-ITC or VP-ITC instruments
(MicroCal / GE Healthcare, Northampton, MA, USA) using 300 mM β-
OG solution containing 1% (v / v) or 7.5% (v / v) DMSO and inhibitors 1–4
at concentrations of 0.75 mM. The solutions were freshly prepared in
25 mM Tris / HCl pH 8, 150 mM NaCl, 2 mM TCEP and were degassed
under vacuum for 10 min. The syringe was ﬁlled with the micellar β-
OG solution and 8 μL aliquots were injected into the calorimeter cell
( V cell = 1.4037 ml) containing buffer. During the ﬁrst few injections
the micelles disintegrated completely. The heats of demicellization,
δh i , were recorded and the initial constant δh i ’s were used to calculate
the heat of demicellization, H 0 demic . The heat of micelle formation
had the opposite sign, i.e., H 0 mic = −H 0 demic . Depending on tem-
perature, 20–30 injections were needed until the CMC of 23–35 mM
was reached in the calorimeter cell and the heat of demicellization
approached zero. The demicellization curves were simulated with a
cooperative association model [ 13 ]. The critical micellar concentra-
tion (CMC) was deﬁned as the midpoint of the titration curve [ 14 , 15 ].
The free energy of micellization followed from 
G  0 mic = RT ln CMC (1)
where RT is the thermal energy and the CMC is expressed in molar
units. 
2.4. Isothermal titration calorimetry (ITC) of inhibitor binding 
Binding experiments of rCPT-2 with inhibitors were performed
with a VP-ITC calorimeter ( V cell = 1.4037 ml; MicroCal / GE Healthcare,
Northampton, MA, USA). rCPT-2 was diluted to 10 μM ﬁnal concen-
tration in 25 mM Tris / HCl pH 8, 150 mM NaCl, 2 mM TCEP, 1% (w / v)
β-OG. In order to avoid problems with signal stability during ITC mea-
surements DMSO was also added to the protein solution in the cell at
a ﬁnal concentration of 1% (v / v). The inhibitor solution (ca. 100 μM in
buffer with 1% (v / v) DMSO and 1% (w / v) β-OG) was injected in 10 μL
steps into a 10 μM rCPT-2 solution in identical buffer. The enthalpy of
reaction, H 0 , the binding constant, K , and the stoichiometry value,
n , were calculated from the measured heat changes, δH i , upon asso-
ciation of the inhibitor with the rCPT-2 target protein. To examine
proton transfer upon binding, titrations with inhibitor 3 were per-
formed in buffers (pH 8) of different ionization enthalpies: HEPES /
NaOH ( H diss = 3.92 kcal / mol), Bicine / HCl ( H diss = 6.27 kcal / mol),
Tris / HCl ( H diss = 11.52 kcal / mol). 
2.5. Measurements of protein stability by thermal unfolding 
Differential scanning calorimetry (DSC) measurements for char-
acterization of thermal protein denaturation were performed on a
MicroCal VP-DSC calorimeter ( V cell = 0.517; MicroCal / GE Healthcare,
Northampton, MA, USA). A scan rate of 30 ◦C / h was used. The protein
concentration was 14 μM ( ±100 μM inhibitor 4) in 25 mM HEPES /
NaOH pH 8.0, 150 mM NaCl, 2 mM TCEP and 30 mM β-OG. The refer-
ence compartment contained buffer only. A blank measurement with
buffer in both compartments was used as baseline. Protein and buffer
solutions were degassed to avoid formation of air bubbles. 
2.6. Fluorescence quenching experiments 
Fluorescence measurements were performed at 20 ◦C with an
SLM-Aminco 8100 double-grating spectroﬂuorometer. The protein
concentration was 2 μM in 25 mM Tris / HCl pH 8, 150 mM NaCl, TCEP
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 nd 1% (w / v) β-OG. The excitation wavelength was 280 nm and pro- 
ein tryptophan ﬂuorescence was recorded at 340 nm. Small aliquots 
f known concentration of inhibitors, dissolved in DMSO, were added 
o the protein solution and each time the ﬂuorescence intensity was 
easured. These ﬂuorescence intensities were corrected for dilution 
nd ligand absorbance [ 16 ], plotted against ligand concentration and 
tted for K D with a single site model as described [ 17 ]. 
.7. Activity assay 
The activity of rCPT-2 (crude lysate from Pichia pastoris expression 
ith 30 nM enzyme concentration) was measured at 30 ◦C for the re- 
erse reaction with a spectrophotometric assay by using 5-5 ′ -dithio- 
is-(2-nitrobenzoic acid), DTNB [ 18 , 19 ]. The HS-CoA released on the 
ormation of acylcarnitine from carnitine (500 μM) and palmitoyl- 
oA (80 μM) reacted with DTNB (300 mM). The resulting 5-mercapto- 
2-nitrobenzoic acid) absorbs at 410 nm with a molar extinction coef- 
cient of 13,600 M −1 cm −1 . The assay buffer contained 25 mM Tris–
Cl pH 7.4, 120 mM KCl and 1 mM EDTA (and no additional β-OG). 
nhibitors 1–4 were titrated from 10 mM DMSO stock solutions. The 
nzyme activity was not measured in the presence of 1% (w / v) β-OG 
ecause in one of the crystal structures a β-OG molecule was bound to 
he acylcarnitine site (see Supplementary data ). β-OG was identiﬁed 
s competitive inhibitor of rCPT-2: with octanoyl-CoA as substrate 
-OG had a K i of 15 mM, which is half the CMC of β-OG [ 19 , 20 ]. In
ddition, Johnson et al. observed “abnormal non-saturation kinetics 
ith respect to palmitoyl-CoA” (presumably due to self-association 
f palmitoyl-CoA at high concentrations) [ 21 ]. These observations led 
s to refrain from determining K i values for inhibitors 1–4. 
.8. X-ray crystallography 
rCPT-2 at 12–18 mg / ml was incubated with a 10-fold molar excess 
f inhibitors (surrogate for inhibitors 1 and 2: [( R )-2-(3,4-dihydro-1H- 
soquinoline-2-carbonyl)-peridin-1-yl]-2-phenoxy-ethanone; surro- 
ates for inhibitor 3: 4- { [1-(5-Chloro-2-methoxy-benzenesulfonyl)- 
-methyl-2,3-dihydro-1H-indole-6-carbonyl]-amino } -benzoic acid 
nd 2-chloro-4- { [1-(5-chloro-2-methoxy-benzenesulfonyl)-4- 
ethyl-2,3-dihydro-1H-indole-6-carbonyl]-amino } -benzoic acid; 
ee Supplementary Data ) and subsequently co-crystallized by vapor 
iffusion. Crystals for the surrogate of inhibitors 1 and 2 were 
btained with 0.1 M bis–Tris pH 6.5, 20% (w / v) PEG–MME 5000 
Index 46, Hampton Research) and 0.05 M magnesium chloride, 0.1 M 
EPES pH 7.5, 30% (v / v) PEGMME 550 (Index 55, Hampton Research) 
nd 0.15 M DL-malic acid pH 7.0, 20% (w / v) PEG 3,350 (Index 91, 
ampton Research); PEG 200 was used in the cryo-buffer. Crystals for 
he surrogates of inhibitors 3 were obtained with 0.2 M ammonium 
ulfate, 0.1 M TRIS / HCl pH 8.5 and 25% (w / v) PEG 3350 (Index 69, 
ampton Research) and 0.2 M lithium sulfate, 0.1 M HEPES pH 7.5, 
5% (w / v) PEG 3,350 (Index 76, Hampton Research). These crystals 
ere ﬂash frozen in liquid nitrogen after exchanging excess mother 
iquor against 100% (v / v) parafﬁn oil. Crystals with inhibitor 4 were 
btained as described [ 8 ]. Data were collected at 100 K at beamline 
10SA of SLS, Villigen, Switzerland, and the crystal structures were 
olved as described [ 7 , 8 ]. 
.9. Binding mode investigation through manual docking of ligands 
Manual modeling and energy minimization of inhibitors 1 and 2 
as carried out with the modeling package Moloc (Gerber Molecu- 
ar Design, Basel, Switzerland). The phenoxy moiety of inhibitors 1 
nd 2 was matched on the phenoxy part of complex structure PDB: 
EYW (inhibitor 1-[( R )-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)- 
iperidin-1-yl]-2-phenoxy-ethanone, see Supplementary Data ). As in 
he X-ray complex structure, the phenoxyacetamid part of inhibitors 
 and 2 was modeled in a fully planar conformation to the binding tunnel. This is a low energy conformation and in agreement with 
conformational analysis of phenoxyacetyls found in the CSD [ 22 ]. In 
this conformation and orientation in the binding tunnel the phenoxy- 
acetyl carbonyle oxygen is able to form a hydrogen bond to a backbone 
N–H of Ser490. Flexibility of inhibitors 1 and 2 is limited due the num- 
ber of ring systems and sp2-centers. This restriction only allows for 
a conformation where the terminal piperidine / piperazine including 
fragments bind to an exposed binding pocket. After energy minimiza- 
tion of the ligand with constrained protein atoms the ligands were in 
an overall low energy conformation with good interactions (hydrogen 
bonding, VdW) to protein atoms. 
3. Results 
3.1. Thermodynamics of micelle formation 
The chemical structure of the inhibitors investigated is given in 
Table 1 . Fig. 1 summarizes the inﬂuence of DMSO and inhibitors 1–4 
on the critical micellar concentration (CMC) of β-OG. Fig. 1 A displays 
the critical CMC of β-OG in buffer with and without addition of DMSO 
as a function of temperature. The data in absence of DMSO are very 
similar to those of previous reports [ 15 , 23 ]. Addition of 1% (v / v) DMSO
shifts the CMC to higher values by about 2–3 mM, and increasing the 
concentration of DMSO to 7.5% (v / v) has an even larger effect with a 6–
8 mM increase of the CMC. The addition of DMSO shields hydrophobic 
interactions of detergent molecules and thus makes micelle formation 
more difﬁcult, which results in an increase of the CMC. 
Fig. 1 B compares micelle formation upon addition of inhibitors 
1–4. The starting solution of the demicellization experiment was typ- 
ically 300 mM β-OG with 0.75 mM inhibitor and 7.5% (v / v) DMSO. 
Diluting this solution to 40 mM β-OG produces an inhibitor concen- 
tration of 100 μM. This corresponds approximately to the standard 
solution used in the protein binding experiments. Inspection of Fig. 
1 B reveals different inhibitor effects on the CMC. The presence of in- 
hibitor 3 has no effect on the CMC of β-OG when compared to β-OG 
alone. Inhibitors 2 and 4 slightly increase the CMC of β-OG. In contrast, 
inhibitor 1 reverses completely the effect of 7.5% DMSO and the CMC 
becomes close to that of pure β-OG without DMSO. The only differ- 
ence between inhibitors 1 and 2 is the polar nitro-group of inhibitor 
1, which could have a speciﬁc interaction with DMSO. 
Fig. 1 C summarizes the temperature dependence of the enthalpy 
of micelle formation, H 0 mic . From the slopes of the linear ﬁts the 
molar heat capacity change of micelle formation can be calculated 
as C 0 p = −60 to −90 cal / mol K, which is typical for a hydrophobic 
aggregation reaction of molecules of the size of β-OG. Van’t Hoff’s 
law was used to calculate the temperature dependence of the CMC 
as shown by the solid lines in Fig. 1 A and B. All thermodynamic data 
are summarized in Table 2 . As a general conclusion it follows that the 
addition of DMSO or inhibitors 1–4 has a small inﬂuence on the CMC 
of β-OG but does not induce signiﬁcant changes of micelle structure 
or micelle–solvent interactions. 
3.2. Inhibitor binding to rCPT-2 measured by isothermal titration 
calorimetry 
Inhibitors were dissolved in micellar β-OG at concentrations of 
100–300 μM and were titrated into 10 μM rCPT-2. A typical titration 
experiment is shown in Fig. 2 A. After an initial exothermic reaction 
the heats of reaction reached a constant value. The heat ﬂows were 
integrated to yield the heats of reaction, δh i , ( Fig. 2 B). The heat of dilu- 
tion towards the end of the reaction was subtracted before evaluating 
the data. The solid line in Fig. 2 B corresponds to a binding model with 
a 1:1 stoichiometry and was calculated with H 0 = −4.7 kcal / mol and 
a binding constant K = 8 × 10 5 M −1 . 
Table 3 summarizes the thermodynamic data derived from ITC 
measurements. The dissociation constants K D = 1 / K determined by 
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Table 2 
Effect of inhibitors 1–4 on micelle formation of β-OG (values measured in absence of rCPT-2). 
Temp. ( ◦C) CMC (mM) H 0 mic (kcal / mol) G 
0 
mic (kcal / mol) T S 
0 
mic (kcal / mol) 
β-OG + no inhibitor 
14 32.8 1 .33 −1.94 3.27 
30 27.8 0 .60 −2.15 2.75 
37 28.6 0 .16 −2.18 2.34 
45 – −0 .54 – –
β-OG + inhibitor 1 
14 24.1 1 .24 −2.12 3.36 
25 23.3 0 .30 −2.22 2.51 
37 24.1 −0 .88 −2.29 1.40 
β-OG + inhibitor 2 
14 34.5 1 .03 −1.91 2.94 
45 33.3 −0 .74 −2.14 1.40 
β-OG + inhibitor 3 
14 32.3 1 .28 −1.95 3.23 
45 29.0 −0 .59 −2.23 1.64 
β-OG + inhibitor 4 
14 35.1 2 .36 −1.90 3.26 
25 31.3 0 .88 −2.04 2.92 
30 31.0 0 .57 −2.08 2.66 
45 31.0 −0 .45 −2.19 1.74 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ITC are supported by the results of ﬂuorescence titrations, which
yielded similar afﬁnities for inhibitors 1–3. The binding reactions of
all four inhibitors followed a 1:1 stoichiometry. Inhibitors 1, 2 and 4
showed exothermic reaction enthalpies in Tris / HCl pH 8 buffer while
the reaction of inhibitor 3 was endothermic under the same condi-
tions. 
The interaction of inhibitors 1 and 2, which according to our mod-
els bind to the CoA-site of rCPT-2 ( Fig. 3 ), was driven to almost equal
extent by enthalpy and entropy. Inhibitor 4 to binds to the acylcarni-
tine binding site of rCPT-2 and this interaction was enthalpy driven.
The entropy term even counteracted the binding because the con-
formational ﬂexibility of the acyl-moiety is frozen upon binding. For
inhibitor 3, which – according to our crystal structures and docking
models – binds to the CoA binding site but with a different bind-
ing mode than inhibitors 1 and 2, binding to rCPT-2 appeared to be
purely entropy-driven in Tris / HCl pH 8.0. Among the tested com-
pounds inhibitor 3 was the only molecule which carried a carboxylic
acid group. Inspection of the crystal structure of rCPT-2 in complex
with inhibitor 3 shows the carboxy-group at a distance of ∼2.8 ˚A from
the side chain of the catalytic His372 ( Fig. 3 ), suggesting that the
endothermic H could have been caused by a proton transfer (see
paragraph on protonation reaction below). This is supported by our
observation that a change to buffers with different dissociation en-
thalpies led to exothermic binding reactions for this compound. 
3.3. Protonation reaction 
Inhibitor 3 carries a carboxylic acid group with a calculated pK a
= 3.5 [ 24 , 25 ], which is deprotonated in the Tris / HCl pH 8 buffer. To in-
vestigate whether proton transfer can occur between the carboxylic
acid group and the catalytic His372, we have measured the bind-
ing of inhibitor 3 to rCPT-2 at pH 8 in buffers with different disso-
ciation enthalpies (25 mM HEPES / NaOH, H diss = 3.92 and 25 mM
Bicine / NaOH, H diss = 6.28). The measured reaction enthalpy, H obs ,
is composed of the intrinsic binding enthalpy, H 1 , of inhibitor 3 to
rCPT-2 plus the additional enthalpies of inhibitor protonation, H 2 ,
and buffer dissociation, H diss . 
H obs = H 1 + n ( H di s s − H 2 ) (2)
where n is the number of protons transferred from buffer to inhibitor.
In Fig. 4 the measured H obs is plotted versus the dissociation en-
thalpies of 3 different buffers. A straight line with n = 0.83 ± 0.17 is
obtained, indicating that the binding of inhibitor 3 to rCPT-2 inducesa protonation of inhibitor 3 by 0.8 H + . The intercept with the ordi-
nate is H 1 –n H 2 = −7.14 kcal / mol. As the dissociation enthalpy of
acetic acid is H 2 = −0.1 kcal / mol [ 26 ] and assuming the same value
for the carboxylate group of inhibitor 3 we ﬁnd an intrinsic binding
enthalpy of H 1 = −7.8 ± 1.3 kcal / mol for inhibitor 3. The binding
of inhibitor 3 to the CoA site is thus driven by a change in enthalpy,
suggesting strong van-der-Waals interactions. 
3.4. Protein stability and ligand binding 
We used differential scanning calorimetry (DSC) to investigate to
which extent ligand binding could stabilize the protein structure. We
measured the thermal unfolding of rCPT-2 both in absence and pres-
ence of inhibitor 4 ( Fig. 5 ). In both experiments a plot of C 0 p versus
temperature showed a broad, asymmetric transition, extending from
30 to 55 ◦C. The midpoints of the transition were at 47.2 ◦C for the
pure protein and at 49.8 ◦C for rCPT-2 bound with inhibitor 4. The
midpoint of unfolding as seen by DSC for the protein without in-
hibitor is in good agreement with a ﬂuorescent-based thermal shift
assay and circular dichroism spectroscopy which determined melting
points as T m = 47.6 ◦C and 47.0 ◦C, respectively [ 7 ]. The integration of
the C 0 p versus temperature curve in the interval 30–55 
◦C yields a total
unfolding enthalpy of 970 kcal / mol for the protein without inhibitor
and 1270 kcal / mol for the protein in excess of inhibitor 4. The rCPT-
2 unfolding does not follow a simple N(ative) U(nfolded) 2-state
transition. Nevertheless, it can be estimated that the observed stabil-
ity increases of ∼3 ◦C together with the measured H -values leads to
a binding constant in broad agreement with that observed by ITC. 
4. Discussion 
rCPT-2 is a 658 amino acid peripheral membrane protein which is
located at the matrix side of the inner mitochondrial membrane. It be-
longs to a class of enzymes where both hydrophobic and hydrophilic
interactions are important. Potential mechanisms to overcome the
phospholipid / water boundaries have been reviewed [ 27 ]. Based on
the crystal structure of rCPT-2 it was suggested that two helices with
hydrophobic residues are submerged by 4–5 A˚ into the core of the
membrane [ 7 ]. The present study explored the potential to perform
thermodynamic binding studies in the micellar detergent environ-
ment necessary for solubilization of active rCPT-2. It was expected
that hydrophobic interactions were reduced in a non-polar environ-
ment whereas electrostatic interactions were increased due to the
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Table 3 
Results of A , ITC and B , ﬂuorescence as well as activity measurements for inhibitors 1–4. See Section 2 for IC 50 and minimum / maximum K i values. 
A 
Inhibitor T ( ◦C) K D ( μM) G 0 (kcal / mol) H 0 (kcal / mol) T S 0 (kcal / mol) Comment 
1 10 1.6 ± 0.4 −7.5 ± 0.1 −3.9 ± 0.9 3.7 ± 0.8 Average ± SEM of two 
replicates 
17 6.6 −6.8 −1.6 5.2 –
2 10 2.0 −7.4 −3.0 4.4 –
17 2.0 −7.5 −5 5.0 –
3 10 5.0 −6.8 −5.0 1.8 25 mM HEPES / NaOH pH 
8 
( H diss = 3.92 kcal / mol) 
10 5.0 −6.8 −1.8 5.0 25 mM Bicine / NaOH pH 
8 
( H diss = 6.28 kcal / mol) 
10 3.3 −7.1 1.6 8.7 C 0 P = 69 cal mol −1 K −1 
17 3.5 −7.2 2.2 9.4 
25 2.9 −7.5 2.6 10.1 
37 5.0 −7.5 3.5 11 
4 10 10.5 ± 3.3 −6.5 ± 0.3 −9.8 ± 0.7 −3.3 ± 0.5 Average ± SEM of three 
replicates 
37 20.0 −5.9 −9.5 −3.7 –
B 
Inhibitor K D ( μM) IC 50 ( μM) 
Fluorescence (20 ◦C) Diluted lysate 
(30 ◦C) 
1 16.2 2.8 
2 15.5 0.15 
3 5.2 0.78 
4 n.d. 0.38 
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tower dielectric constant of the solvent. So far, there is only limited 
alorimetric data available for ligands binding to detergent solubilized 
embrane proteins [ 28 , 29 ], or the interaction of small molecules or 
eptides with phospholipids [ 11 , 12 ]. 
Fig. 3 shows the superposition of inhibitors 1–4 (or analogs thereof, 
ee Supplementary Data ) on the rCPT-2 active site. Inhibitors 1–3 bind 
o the CoA binding site, while inhibitor 4 (ST1326) binds to the acyl- 
arnitine site. Two different modes of interaction were found for CoA 
ite binders. The piperidine derivatives (inhibitors 1 and 2) inter- 
ct with residues of β-strand 13 (Ser490) and a pocket created by 
he subsequent loop (Ala492, Ala493) and β-strand 2 (Phe176). In- 
ibitor 3 of the sulfonamide class interacts directly with the catalytic 
is372 via its carboxy-group as well as with residues of the loop 
hat connects β-strands 15 and 16 (Thr 591, Leu 592, Asn 593). In 
he presence of inhibitors of the sulfonamide class the peptide bond 
etween Asp376 and Gly377 adopts a conformation such that the 
mide nitrogen atom of Gly377 points towards the carboxyl-group 
f the inhibitors. Thereby a hydrogen-bond network between the 
atalytic loop (Glu371–Gly377) and the inhibitor is established, for 
hich direct evidence is provided by the protonation of the inhibitor 
arboxy-group observed in the ITC experiments. We have previously 
ecognized the peptide ﬂip between residues Asp376 and Gly377 and 
ts potential utilization as anchor-point for CPT inhibitors targeted 
gainst the CoA site [ 7 ]. With inhibitor 3 of the sulfonamide class of 
PT-2 inhibitors we provide a ﬁrst example. In the case of inhibitor 
, the C14 alkyl-chain occupies an essentially hydrophobic tunnel 
panning from the active site of the protein to its surface [ 7 ], while 
he hydrophilic carnitine head-group is bound in a hydrogen network 
omprising residues of the catalytic loop, α-helix 5 (Tyr120) and β- 
trands 15 and 16 and an additional cation- π interaction with Phe602. 
he reduction of the conformational ﬂexibility of the alkyl-chain and 
he formation of the hydrogen network upon binding of ST1326 to 
CPT-2 explains both the negative entropy and the large exothermic 
nthalpy of the binding reaction observed in ITC experiments. 
In the present study we investigated which thermodynamic forces 
overn the interaction between rCPT-2 and its substrates. Isothermal 
itration calorimetry measures the reaction enthalpy, H 0 , but also provides the dissociation constant K D from the shape of the titration 
curve. The dissociation constants determined by ITC are in the range 
of 2 μM (inhibitor 1) to 20 μM (inhibitor 4) and values of the same 
order of magnitude were measured with ﬂuorescence titrations. The 
differences in K D values between ITC and ﬂuorescence spectroscopy 
must be attributed to the different assay conditions. In addition, β-OG 
can bind to the acylcarnitine binding site of rCPT-2 and inhibit its ac- 
tivity (see Section 2 and Supplementary data ). When compared to the 
ITC experiments, lower protein concentrations have to be used and 
the inhibitors are added from DMSO stock solutions for our standard 
ﬂuorescence spectroscopy protocol. A lower ratio of rCPT-2 to β-OG 
and thus a higher fraction of β-OG micelles without rCPT-2 inser- 
tion could reduce the apparent afﬁnity of the inhibitors for rCPT-2 in 
the ﬂuorescence titrations, especially with regard to partition of in- 
hibitors 1 and 2 into β-OG micelles ( Fig. 1 , Table 2 ). Along these lines, 
the similar K D values of the ITC and ﬂuorescence titration results in 
the case of inhibitor 3 agrees with the observation that inhibitor 3 
had no effect on the CMC of β-OG. 
In contrast to the binding assays the enzymatic activity measure- 
ments were made with diluted rCPT-2 extracts without additional 
detergent and, thus, the hydrophobic solvent effects were strong. The 
non-polar reaction partners were hydrated and water molecules were 
released upon binding, leading to a strong positive entropy contribu- 
tion to binding. In contrast, 1% (w / v) β-OG was used in the ITC ex- 
periments and consequently rCPT-2 and the inhibitors were already 
embedded in a hydrophobic, micellar environment and the molecules 
were hydrated to lesser extent. The hydrophobic effect was accord- 
ingly reduced. The solvent effect was particularly pronounced for 
inhibitor 4 which carries a C14 aliphatic chain. In the aqueous phase 
the hydrophobic effect of this residue was dominant, whereas the 
hydrophobic effect was essentially eliminated in the presence of mi- 
cellar β-OG and the entropy contribution became negative. 
As mentioned in Section 1 , the binding of cynnamycin, a 19 aa 
tetra-cyclic peptide, to phospholipids with the phosphoethanolamine 
(PE) headgroup was compared in water and in micellar phase [ 11 , 12 ]. 
The free energy of binding, G 0 , was by 1–2.5 kcal / mol less negative 
in β-OG micelles than in the aqueous phase. The binding constants of 
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Fig. 1. Critical micellar concentration (CMC) of β-octyl glucoside ( β-OG) in the pres- 
ence of DMSO and rCPT-2 inhibitors 1–4. (A) Inﬂuence of DMSO on CMC of β-OG in 
absence of inhibitors. ( ) β-OG without DMSO, (  ) β-OG + 1% (v / v) DMSO, ( •) β-OG 
+ 7.5% (v / v) DMSO. (B) Inﬂuence of 7.5% (v / v) DMSO on CMC of β-OG in presence of 
inhibitors. The inhibitor concentration at the CMC varies between ca. 70–100 μM. ( •) 
β-OG only, (  ) β-OG + inhibitor 1, (  ) β-OG + inhibitor 2, (  ) β-OG + inhibitor 3, 
( ) β-OG + inhibitor 4. (C) Enthalpy of micelle formation as a function of temperature. 
( •) β-OG, (  ) β-OG + inhibitor 1, (  ) β-OG + inhibitor 2 (  ) β-OG + inhibitor 3, ( ) 
β-OG + inhibitor 4. 
 
 
Fig. 2. Calorimetric titration of rCPT-2 with inhibitor 1 at 10 ◦C. The inhibitor (140 μM) 
was injected with 25 steps of 10 μl into the calorimetric sample cell containing 11 μM 
of rCPT-2. (A) Heat ﬂow as a function of time. (B) Reaction enthalpy, δh i , of inhibitor 1 
versus injection number. The solid line corresponds to the theoretical model assuming 
a 1:1 binding stoichiometry, a reaction enthalpy of H 0 = −4.7 kcal / mol and a binding 
constant of K = 8 × 10 5 M −1 . Buffer composition: 25 mM Tris / HCl pH 8, 150 mM NaCl, 
2 mM TCEP, 1% (w / v) β-OG, 1% (v / v) DMSO. 
Fig. 3. Structures of rCPT-2 with bound inhibitors 1–4 as determined by X-ray crys- 
tallography and computational modeling. (A) Superposition of crystallographic and 
modeled structures of complexes of rCPT-2 with inhibitors 1 and 2 (blue and yellow, 
respectively, both modeled based on the crystal structure of a related piperidine class 
inhibitor, see Supplementary Data ), the two isosteric surrogates of inhibitor 3 (cyan 
and green) and inhibitor 4 (ST1326, magenta). The solvent accessible surface of the 
carboxy-terminal domain of rCPT-2 (off-white, L441-I656) is shown with hydrophobic 
residues depicted in green and polar residues shown in orange. The amino terminal 
domain was removed for clarity. (B) Detail of the complex structure of rCPT-2 (green) 
with a surrogate of inhibitor 3 (cyan) that shows the interaction of the benzoic acid 
head group of this inhibitor class with the catalytic residue His372. The minimum 
distance is 2.8 A˚. The ﬁnal 2FoFc electron density of the structure is shown as gray 
mesh. (For interpretation of the references to colour in this ﬁgure legend, the reader is 
referred to the web version of this article.) 
 
 
 
 
 
 
 the PE–cinnamycin complex were thus 10–100 times smaller in the
β-OG environment [ 12 ] supporting the above conclusion of reduced
hydrophobic interactions in the presence of β-OG. Electrostatic interactions are increased in a non-polar micellar en-
vironment because of the lower dielectric constant. Charge neutral-
ization reactions are then characterized by substantial positive heat
capacity changes, C 0 p [ 30 ]. Electrostatic effects were revealed by the
temperature dependence of the reaction enthalpy, H 0 . Inhibitor 3
in Tris / HCl pH 8 buffer showed a linear dependence on temperature
with a positive molar heat capacity change of C 0 p = 69 cal / mol K
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Fig. 4. Proton transfer upon binding of inhibitor 3. The measured binding en- 
thalpy for the interaction of inhibitor 3 with rCPT-2, H obs , is plotted ver- 
sus the ionization enthalpies of different buffers. Measurements were made in 
HEPES / NaOH ( H diss = 3.9 kcal / mol), Bicine / NaOH ( H diss = 6.3 kcal / mol) and Tris / 
HCl ( H diss = 11.5 kcal / mol) at pH 8 and 10 ◦C. The solid line is the linear regression 
analysis of the data. 
Fig. 5. Experimental DSC scans on rCPT-2 with and without inhibitor 4. Black line: 
rCPT-2, no inhibitor, Red line: rCPT-2 in the presence of inhibitor 4. rCPT-2 concen- 
tration 14 μM, inhibitor 4 concentration 100 μM; buffer conditions as in Fig. 2 . (For 
interpretation of the references to colour in this ﬁgure legend, the reader is referred to 
the web version of this article.) 
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i Table 3 ). For the other inhibitors only two temperatures were mea- 
ured. The C 0 p values ranged from 314 cal / molK of inhibitor 1 to 
nly 11 cal / mol K of inhibitor 4. The very small C 0 p of inhibitor 4 
ndicates that electrostatic interactions ( C 0 p > 0) were almost com- 
letely compensated by hydrophobic interactions ( C 0 p < 0). 
Table 3 contains the enthalpic and entropic components to the 
ree energy change, G 0 . For inhibitors 1 and 2 enthalpy and en- 
ropy contribute to equal extent to the binding afﬁnity. For inhibitor 
 the free energy is exclusively enthalpic and the entropy term close 
o zero if the protonation reaction is neglected. The binding of in- 
ibitor 4 is also enthalpy-driven and shows the most negative H 0 
f ∼−10 kcal / mol while the entropy is even counteracting binding. 
evertheless, the binding constants and the free energies of bind- 
ng of the 4 inhibitors are rather similar in spite of quite different 
ontributions of H 0 and T S 0 . The binding of the four inhibitors is 
hus another example of the enthalpy–entropy compensation effect. 
he interpretation of H 0 and T S 0 in terms of molecular structures 
s difﬁcult, but it is common to associate H 0 with van-der-Waals and electrostatic interactions. However, as these are increased, the 
molecular structure of the ligand–protein complex rigidiﬁes and the 
loss in conformational freedom produces a negative T S 0 term which 
reduces the gain in enthalpy. 
In summary, measuring the ligand afﬁnities with ITC has added 
valuable information on binding modes that can be reconciled with 
the crystallographic data and docking models. However, the absolute 
values for binding constants from orthogonal binding assays need to 
be evaluated regarding the sample composition that is required for 
each of the methods. 
The micromolar K D -values of inhibitors 1–4 are not sufﬁcient for 
pharmaceutical purposes and should be reduced to the nanomolar 
range to increase the potency of the compounds. The challenge there- 
fore is to optimize both H 0 and T S 0 . Calorimetric measurements 
will be helpful in verifying different synthetic concepts. 
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